Showing results (971-980 of 6,669) with videos related to
Sort By:
Pageof 667
Annals of Hematology|October 1, 2016
Endothelial progenitor cells improve the quality of transplanted hematopoietic stem cells and maintain longer term effects in miceJianlin Qiao, Lan Ding, Jinyu Fu, et al.Annals of Hematology|October 15, 2016
Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trialsMaria-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, et al.Annals of Hematology|March 25, 2017
A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H diseasePacharapan Surapolchai, Ampaiwan Chuansumrit, Nongnuch Sirachainan, et al.Annals of Hematology|April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromesFelicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.Annals of Hematology|September 14, 2014
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trialStephan Kreher, Felicitas Strehlow, Peter Martus, et al.Annals of Hematology|September 16, 2014
Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)A M Pfeil, P Imfeld, R Pettengell, et al.Annals of Hematology|October 7, 2014
Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemiaJ Loke, J N Khan, J S Wilson, et al.Annals of Hematology|October 12, 2014
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatmentMassimo Breccia, Matteo Molica, Irene Zacheo, et al.Annals of Hematology|September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.Annals of Hematology|August 2, 2014
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patientsSeok Jin Kim, Silvia Park, Eun Suk Kang, et al.Pageof 667